【高端访谈】“自主研发+协同创新”双轮驱动 公司迈入新发展阶段—访先声药业周云曙

新华财经
Aug 31

新华财经南京8月31日电(记者朱程)2026年上半年,先声药业交出了一份亮眼成绩单:总营收45.8亿元,同比增长27.8%;经调整净利润9.6亿元,同比增长48.7%;创新药收入占比攀升至85%。  这份业绩如何取得?先声药业的国际化布局有哪些新部署?AI制药未来会如何改变行业?近日,记者带着这些问题专访了先声药业集团总裁周云曙。  10款创新产品组合成型企业进入收获期  成立于1995年的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10